Vanessa has over 24 years industry experience providing biopharmaceutics support to discovery, development and clinical programs. Vanessa has previous experience at AstraZeneca as a permeability expert working in the Pharmaceutical Development dept. where she led the global Caco-2 facility for development, liaising with discovery scientists to ensure selection of NCE with appropriate biopharmaceutical properties. Vanessa joined Quotient Sciences in 2012 and has led the implementation of Modelling and Simulation and been heavily involved in the Pharmaceutical Sciences in vitro characterization strategy, as well as designing clinical studies and providing scientific support through clinical study delivery. Vanessa has provided scientific support to over 100 clinical studies, many involving formulation optimization for poorly soluble compounds and modified release formulations.
Vanessa Zann
